Disability improvement in relapsing-remitting multiple sclerosis patients receiving cladribine tablets, evaluated by expanded disability status scale

被引：0
|
作者：
Sormani, M. P. [1 ,2 ]
Giovannoni, G. [3 ]
Signori, A. [1 ]
Alexandri, N. [4 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] Osped Policlin San Martino, Genoa, Italy
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England
[4] Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0201
引用
收藏
页码：215 / 215
页数：1
相关论文
共 50 条
  • [31] Improvement of disability level with Enkorten therapy in patients suffering from relapsing-remitting multiple sclerosis (RRMS)
    Alajbegovic, A.
    Mehmedika-Suljic, E.
    Merhemic, Z.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S207 - S207
  • [32] Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients
    Bjerg, Lasse
    Brosbol-Ravnborg, Anne
    Torring, Caroline
    Dige, Anders
    Bundgaard, Bettina
    Petersen, Thor
    Hollsberg, Per
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 249 (1-2) : 76 - 82
  • [33] Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis (vol 25, pg 239, 2011)
    Muir, Victoria J.
    Plosker, Greg L.
    CNS DRUGS, 2020, 34 (04) : 447 - 447
  • [34] Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
    Renée Else Michels
    Maria De Francesco
    Koshu Mahajan
    Gerald J. D. Hengstman
    Krijn M. H. Schiffers
    Sangeeta Budhia
    Gerard Harty
    Marieke Krol
    Applied Health Economics and Health Policy, 2020, 18 : 141 - 141
  • [35] Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells
    Ammoscato, Francesca
    Wafa, Mohammad
    Skonieczna, Justyna
    Bestwick, Jonathan
    Monero, Rosemary
    Andrews, Michael
    De Trane, Stefania
    Holden, David
    Adams, Ashok
    Bianchi, Lucia
    Turner, Ben
    Marta, Monica
    Schmierer, Klaus
    Baker, David
    Giovannoni, Gavin
    Gnanapavan, Sharmilee
    CLINICAL IMMUNOLOGY, 2024, 269
  • [36] A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
    Mazdeh, Mehrdokht
    Monhaser, Shahriar Kargar
    Taheri, Mohammad
    Ghafouri-Fard, Soudeh
    CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
  • [37] Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis
    Greenberg, Benjamin M.
    Balcer, Laura
    Calabresi, Peter A.
    Cree, Bruce
    Cross, Anne
    Frohman, Teresa
    Gold, Ralf
    Havrdova, Eva
    Hemmer, Bernhard
    Kieseier, Bernd C.
    Lisak, Robert
    Miller, Aaron
    Racke, Michael K.
    Steinman, Lawrence
    Stuve, Olaf
    Wiendl, Heinz
    Frohman, Elliot
    JAMA NEUROLOGY, 2013, 70 (02) : 248 - 251
  • [38] Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis
    Stewart, T.
    Jokubaitis, V.
    Spelman, T.
    Havrdova, E.
    Horakova, D.
    Trojano, M.
    Izquierdo, G.
    Girard, M.
    Duquette, P.
    Prat, A.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Sola, P.
    Hupperts, R.
    Petersen, T.
    Pucci, E.
    Bergamaschi, R.
    Boz, C.
    Oreja-Guevara, C.
    Lechner-Scott, J.
    Alroughani, R.
    Ramo, C.
    Van Pesch, V.
    Fernandez-Bolanos, R.
    Iuliano, G.
    Rio, M. E.
    Granella, F.
    Slee, M.
    Verheul, F.
    Spitaleri, D. L. A.
    Amato, M. P.
    Hodgkinson, S.
    McCombe, P.
    Cabrera-Gomez, J. A.
    Barnett, M.
    Flechter, S.
    Olascoaga, J.
    Vucic, S.
    Sanchez-Menoyo, J. L.
    Cristiano, E.
    Saladino, M. L.
    Moore, F.
    Gray, O.
    Shuey, N.
    Rozsa, C.
    Singhal, B.
    Shaw, C.
    Butzkueven, H.
    Kalincik, T.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 726 - 728
  • [39] Cognitive decline predicts disability progression in relapsing-remitting multiple sclerosis
    Vermersch, Patrick
    Leuse, Delphine
    Cabaret, Maryline
    Outteryck, Olivier
    de Seze, Jerome
    Dujardin, Kathy
    Zephir, Helene
    MULTIPLE SCLEROSIS, 2008, 14 : S266 - S266
  • [40] Interferon-beta and disability progression in relapsing-remitting multiple sclerosis
    Drulovic, Jelena
    Kostic, Jelena
    Mesaros, Sarlota
    Basuroski, Irena Dujmovic
    Stojsavljevic, Nebojsa
    Kisic-Tepavcevic, Darija
    Pekmezovic, Tatjana
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S65 - S69
12345